Skip to content

Clinical trials

Recruiting Phase 2 Lupus Erythematosus, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Status: Recruiting Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20221
20232
20241
20255
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
AstraZeneca1
Autolus Limited1
Beijing InnoCare Pharma Tech Co., Ltd.1
Boehringer Ingelheim1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Eisai Co., Ltd.1
Fate Therapeutics1
Guangdong Hengrui Pharmaceutical Co., Ltd1
Hangzhou Sumgen Biotech Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic21
Lupus Nephritis6
Arthritis, Rheumatoid2
Autoimmune Diseases2
Scleroderma, Systemic2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Antiphospholipid Syndrome1
Arthritis, Juvenile1
Arthritis, Psoriatic1
Behcet Syndrome1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.